Magda Szubanski has provided fans with a heartfelt and surprisingly upbeat update as she battles stage four cancer.

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new treatment options.

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma in adults globally. 1 In the USA, DLBCL accounts for approximately one-quarter of all mature non-Hodgkin’s lymphomas, while ...

Neck ultrasound, on its own, is inadequate for a thorough assessment of nonpalpable lymph nodes in head and neck cancer staging. Nevertheless, it could serve as the sole imaging option in low-resource ...

The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing ...

When Rachel Evans developed a rash that made her feel as though she had 'insects crawling all over her body', doctors ...

GET IT CHECKED!!! If the doctor pooh-poohs it, get it checked by a different doctor. Ultimately, what you do is up to you, ...

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care ...

Head and neck cancer arises in the mucosal epithelium, most often in the oral cavity, followed by the larynx and pharynx.

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysis ...